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ABSTRACT 
Objective: Andrographis paniculata (A. paniculata) Nees is an important medicinal plant found in the tropical regions and has been traditionally 
used in Indian and Chinese medicinal systems. A. paniculata is found to exhibit anti-snake venom properties; however its inhibitory potential on 
multi-toxic Phospholipases A2 and its associated inflammatory reactions is not clearly understood. Henceforth, in this study we evaluate the 
inhibitory/neutralizing potential of alcoholic extract of A. paniculata on the isolated multi-toxic PLA2 (of Daboii rusellii pulchella and Naja naja) and 
its induced edema in Swiss albino mice. 
Methods: The multi-toxic-svPLA2-VRV-PL-V from the venom of Daboii rusellii pulchella was purified according established methods. The inhibition 
of enzymatic activity and edema inducing activity was carried out according to established methods. 
Results: A. paniculata extract dose dependently inhibited the multi-toxic svPLA2 enzymatic activity with an IC50 value of 12.4±0.6 µg/ml. Further, the 
extract dose dependently inhibited the edema formation, when co-injected with the enzyme indicating a strong correlation between lipolytic 
activity and pro-inflammatory activity. 
Conclusion: The ethanolic extract of A. paniculata effectively inhibited the multi-toxic svPLA2 and its associated edema inducing activities, which 
substantiate their anti-ophidian properties. Further study is interesting to develop them into potent anti-ophidian agents. 
Keywords: Snake venom, Neutralization, Drug, Antivenom, Cocktail of inhibitors. 
 
INTRODUCTION 
Snake bite is a public health problem causing considerable high 
morbidity and mortality around the world, particularly in the 
tropics. Snake bite is now recognized as a highly 
Neglected Tropical Disease (NTD) by the World Health Organization 
(WHO) [1, 2]. The World Health Organization (WHO) estimates that, 
globally, at least 4, 21, 000 envenoming and 20,000 deaths occur 
each year due to snake bite [1]. Snake venom is a cocktail of 
biologically active components, which are able to interfere with the 
biological processes in both prey and human [3, 4]. The 
pathophysiological effects observed in snake bite is due to the 
combine action of several enzymatic proteins and peptides, that 
includes phospholipases A2, 5`Nucleotidase, hemorrhagic 
metalloproteases, proteolytic enzymes, proteins acting on coagulant 
components, neurotoxins, cytotoxins, cardiotoxins etc. [3, 4].  
Snake venom phospholipases A2 (svPLA2s) are the principal 
component of snake venoms and have been extensively investigated 
as they have a wide range of biological effects of the wide variety of 
physiological and pathological effects [5-7]. In addition to their 
possible role in the digestion of prey, snake venom sPLA2s exhibit a 
wide spectrum of pharmacological effects such as neurotoxicity, 
cardiotoxicity, myotoxicity, anticoagulant, anticancer effects etc. [5, 
6]. Due to the prominent role played by PLA2s in the snake 
envenomation, there is pharmacological interest in search of svPLA2 
inhibitors [8, 9]. Further, considering the limitations of anti-serum 
therapy [10, 11], researches are focusing on development of 
alternative treatments and in this regard finding inhibitors of the 
multi-toxic svPLA2s from medicinal plants have gained much 
interest [7, 12, 13]. In this context, many svPLA2 inhibitors have 
been isolated from various medicinal plants [8, 9]. Several snake 
venom PLA2 inhibitors are demonstrated to bring down the toxic 
and lethal effects of several venoms, and thereby help in 
management of snake bite [11].  
Andrographis paniculata Nees (Acanthacae) commonly known as 
king of bitters, is widely distributed medicinal herb in tropical Asian 
countries including India. It has been diversely used as the medicinal 
herb in traditional medicinal systems of India, China, Thailand and 
Europe [14]. As evident from Indian Pharmacopoeia, A. paniculata is 
known to prominent in 26 ayurvedic formulations; while in 
traditional Chinese medicine, due to its important “cold property” is 
used to release body heat in fever [15]. The species is 
therapeutically well explored and effectively used for treatment of 
asthma, gonorrhea, piles, dysentery and dyspepsia, influenza, gastric 
complaints, diarrhea, pharyngitonsillitis, fever, myocardial ischemia, 
common cold, diabetes, respiratory tract infections, jaundice among 
others [14, 15]. It is reported to possess antimicrobial, hypotensive, 
anti-hyperglycaemic, oxygen radical scavenging, anti-
atherosclerotic, anti-malarial, anti-HIV, antiplatelet aggregation, 
hepatic lipid peroxidation protective, hepatoprotective, choleretic, 
and anticancer activities. The plant extracts has also been reported 
to exhibit anti-typhoid, antifungal, antifertility, anti-nematicidal, 
anti-hepatitic, anti-hypogycemic, anti-ulcerogenic, anti-
thrombogenic properties, anti-inflammatory and anti-snake venom 
activities [14-16]. In regard to treatment of snake bite, from long 
time back A. paniculata has been used in traditional herbal medicine 
[17-21]. It is used by tribes to treat victims of snake bites in rural 
areas of southern India especially in Andhra Pradesh and Tamilnadu 
[22-24]. It is observed that it had potent neutralization effect on the 
lethal effects of Indian Cobra (Naja naja), King Cobra (Ophiophagus 
hannah), and Rattlesnake (Crotalus adamenteus) venoms [25-27]. It 
was also shown the extract completely inactivated the neurotoxin of 
the C. adamenteus venom [25]. In this study, investigations were 
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carried to evaluate the modulatory effect of ethanolic extract of A. 
paniculata on multi-toxic PLA2 (VRV-PL-V phospholipase A2 
enzyme) from Indian Russell’s viper (Daboia russelii pulchella) 
venom to substantiate their anti-ophidian properties.  
MATERIALS AND METHODS 
Materials 
Venom of Daboia russelii (Russell’s viper) was purchased from Irula 
Co-operative Society Ltd., Chennai, India. Urosolic acid was 
purchased from Sigma chemicals, USA. All other reagents and 
chemicals used were of all analytical grades purchased from Sisco 
Research Laboratories (SRL), Bangalore, India. 
Collection of plant and extraction of crude extract 
Andrographis paniculata plant was collected from nearby areas of 
Thanjavur district, Tamil Nadu. The plant was authenticated at the 
Centre for Research in Indian Systems of Medicine (CRISM), SASTRA 
University, Thanjavur, Tamil Nadu, where a voucher specimen 
(SASTRA/CRISM/PL/182) was deposited. The plant collected of free 
of disease and injury, was washed several times with distilled water 
and shade dried. The powdered plant (40g dry weight) was 
extracted using 95% ethanol (400 ml) in soxhlet extractor solvent 
and extract was concentrated using rotary vacuum evaporator and 
the residue obtained (Dark brown in color), was dried, weighed and 
was preserved in airtight glass container and kept at 4 °C until 
further applications. 
Animals  
Swiss Wister albino mice weighing about 20-25 g were obtained 
from the central animal house facility. All protocols of animal 
experiments have been approved by the SASTRA University-
Institutional Animal Care and Use Committee (IACUC). Animal care 
and handling were conducted in compliance with the national 
regulations for animal research.  
Isolation of multi-toxic (VRV-PL-V) secretary phospholipase A2  
The multi-toxic svPLA2 from the venom of Daboii rusellii pulchela 
(Southern region) was purified up to homogeneity as described 
previously by the method of Kasturi & Gowda [28], and as modified 
by Srinivasan, [29]. These proteins were further used for evaluating 
the anti-inflammatory potential of ethanolic extract of A. paniculata. 
The protein concentration was estimated according to the method of 
Lowry et al. [30] using BSA as the protein standard.  
Inhibition of multi-toxic svPLA2 activity by A. paniculata 
ethanolic extract 
The Phospholipase A2 assay was carried out according to the method 
as described by Bhat and Gowda, [31]. Phosphatidyl choline (PC) 
was diluted with petroleum ether (60–80oC) to get a concentration 
of 1000 nmoles/50 ml. The reaction mixture containing VRV-PL-V (3 
µg) was made up to 680 ml with water. To the reaction mixture, 200 
µl of ether, 100 µl of Tris-HCl buffer (0.05 M, pH 7.5), and 20 µl of 
CaCl2 (500 mM) were added. The total reaction mixture was 
incubated at 37 °C for 60 minutes. After incubation, 0.5 ml of Doles 
mixture (Isopropanol: Pet ether: 1NH2SO4, 40:10:1) was added, 
mixed and centrifuged at 1000 rpm for 3 min. To the organic phase 
0.5 ml of CHCl3: Pet ether (1:5) was added, mixed and centrifuged at 
1000 rpm for 3 min. To the upper phase cobalt reagent [1.35 vol. of 
Triethanolamine made up to 10 ml with solution A (6 g of CO 
(NO3)2.-6H2O+0.8 ml glacial acetic acid) and 7 ml of solution B 
(Saturated Na2SO4)] was added, mixed and centrifuged 1000 rpm for 
3 min. The upper organic phase was carefully transferred and 0.75 
ml of α-nitroso-β-naphthol reagent (0.4% α-nitroso-β-naphthol in 
96% ethanol) was added. The intensity of the orange colour is 
directly proportional to the amount of cobalt present. After 30 min 2 
ml of ethanol was added to dilute the contents and absorbance was 
read at 540 nm. The amount of free fatty acid released was 
estimated using standard linolenic acid curve. The enzyme activity 
was expressed as n moles of fatty acid released/min/mg of protein. 
For inhibition studies, VRV-PL-V (3 µg) was pre incubated with or 
without different concentrations of ethanolic extract of A. paniculata 
(0-25 µg/ml) at 37 °C for 15 min. Appropriate controls were carried 
and further experiments were carried out as described above. The 
inhibition is expressed as percentage taking activity of venom alone 
as 100%. IC50 values were calculated using Graphpad version 5.0. 
Neutralization of edema inducing activity by A. paniculata 
ethanolic extract 
The procedure as modified by Vishwanath et al. [32] was followed. 
VRV-PL-V (5 µg) was pre-incubated without or with different 
concentration of ethanolic extract of A. paniculata (0-100 µg/ml) in a 
total volume of 20 µl saline. The reaction mixture was injected into 
intra plantar surface of right hind footpad of mice weighing 20–25 g. 
The left footpad that received 20 µl of saline served as control. After 
45 min the mice were sacrificed by giving anaesthesia 
(Pentobarbitone, 30 mg/kg, i. p.) and both hind limbs were removed 
at the ankle joint and weighed individually. The increase in weight 
due to oedema is expressed as the ratio of the weight of an 
oedematous limb to the weight of normal (sham injected) limb x 
100. Minimum edema dose is defined as the microgram of protein 
causing an edema ratio of 120%. Injecting a fixed dose protein into 
mice footpads and sacrificing them at the regular period of time 
obtained the time course curve of edema inducing activity. Edema 
ratio was calculated and expressed as %.  
Statistical analysis 
The IC50 values were calculated using Graph Pad version 5.0. 
Inhibition percentages were calculated from the difference between 
inhibitor-treated group and control animals, which received the 
vehicle. Student's t-test for comparisons of unpaired data was used 


















Fig. 1: Dose dependent inhibition of svPLA2 (VRV-PL-V) 
activities by ethanolic extract of A. paniculata 
Briefly, Phosphatidyl choline (PC) corresponding to 1000 nmoles/ml 
was made up to 680µl with VRV-PL-V (3 µg), with or without 
ethanolic extract of A. paniculata at various concentrations (0-25 
µg/ml) and was incubated with other reaction mixture at 37 °C for 
60 min and color developed was read at 540 nm. The results 
















Fig. 2: Dose dependent neutralization of edema inducing 
activity of svPLA2 (VRV-PL-VIIIa) activities by ethanolic extract 
of A. paniculata 
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The reaction mixture 30 µl containing VRV-PL-V (5 µg) was 
incubated for 30 min with increasing concentration of ethanolic 
extract of A. paniculata (100 µg/ml) of M. indica. Saline (30 µl) 
injected into the mouse foot-pad served as control. Data 
represents±SEM for n=3. 
 
Table 1: Specific activity of VRV-PL-V and IC50 values 
sPLA2 Specific activitya IC50b 
VRV-PL-V 142.1±4.3 12.4±0.6 µg/ml 
anmoles of fatty acid released/mg of protein/min at 37 °C, bIC50 value 
is defined as the amount of extract (µg/ml) required to inhibit 50% 
of enzyme activity in the given reaction mixture 
 
RESULTS AND DISCUSSION 
It is observed that effective inhibitors of svPLA2 are known to suppress 
the toxic and lethal effects, which includes inflammation and its 
associated process [8]. In these line of studies, when evaluated anti-PLA2 
potential of A. paniculata against multi-toxic PLA2 of Daboii rusellii 
pulchella i.e., VRV-PL-V, it was observed that the ethanolic extract of A. 
paniculata inhibited the enzymatic activity in a concentration dependent 
manner and the extent of inhibition was>95% at 25 µg/ml (fig. 1), with 
an IC50 value of 12.4±0.6 µg/ml (table. 1).  
It is observed that svPLA2s are known to induce edema when 
injected into mouse footpad as demonstrated before [32]. It is also 
observed that there are many inflammatory mediators which 
participate in the production of edema in a variety of inflammatory 
conditions [33]. Among others, histamine, prostaglandins, kinins and 
leukotrienes, could be implicated in the resulting edema due to 
PLA2s in the case of snake venoms [34, 35]. The edema induced by 
snake venom PLA2s, follows the classical two phases, which is 
characterized by a rapid initial first phase produced by mediators 
such as histamine and serotonin, and a delayed second phase 
mediated by prostaglandins that were as described in mice [34, 35]. 
Several svPLA2 inhibitors are demonstrated to exhibit the 
concomitant inhibition of both enzyme activity and edema-inducing 
activity [7, 8]. From our earlier studies, based on the dose-response 
edema responsive reaction of multi-toxic-VRV-PL-V, a challenge 
dose of 5 µg was selected; due to its effective inflammatory result 
without damaging the overall physical integrity of animal, and help 
in the determination of the anti-inflammatory activity of A. 
paniculata [7]. It was observed that, when the ethanolic extract of A. 
paniculata was co-injected with VRV-PL-V, the extract significantly 
in a dose dependent manner reduced the edema formation (fig. 2). 
In addition, A. Paniculate extracts at the tested dose alone did not 
induce edema when injected into mice footpads. Urosolic acid 
inhibited the edema at all times after svPLA2 injection (results not 
shown). Since the extract significantly inhibits edema formation it is 
most likely that the compounds in these extracts are directly 
interacting with PLA2s activity and thus, acts on the first and second 
phases of this inflammatory response, as reported by others [34, 
35]. A. paniculata has already been reported to inhibit carrageenan 
induced oedema showing statistically significant anti-inflammatory 
activity [36]. Andrographolide, which is one of the therapeutically 
important constituents of A. paniculata is known to significantly, 
inhibit carrageenan-; kaolin-and nystatin-induced paw oedema [37]. 
Further, it is reported that dehydroandrographolide, 
andrographolide and neoandrographolide exhibited strong anti-
inflammatory activity by inhibiting COX-1 expression in ionophore 
A23187-induced human platelets; LPS stimulated COX-2 activity in 
human blood. Also, andrographolide is known to modulate the level 
of LPS-induced TNF-α, IL-6, IL-1β and IL-10 secretion in human 
blood [37, 38]. Our study further confirms the anti-inflammatory 
potential of A. paniculata using Daboii rusellii pulchella venom multi-
toxic PLA2 (VRV-PL-V) as inflammation inductor. In an earlier study, 
the terpeinoids fractions of A. paniculata was shown to neutralized 
the rattle snake (Crotalus adamanteus) venom activities [25]. 
Further, andrographolide which is a labdane diterpenoid and the 
main bioactive component of A. paniculata was shown to inhibit O. 
hannah venom activity [27]. From docking studies, it has been 
observed that andrographolide having significant binding activity 
against disintegrins, aggretin, echicetin, acutolysin C, denmotoxin 
and haditoxin [39]. Henceforth, it can be assumed that this active 
molecule might be the responsible for inhibiting the multi-toxin-
VRV-PL-V PLA2 activities.  
Although at this point the mechanism of action of the extract is 
unclear and based on the finding that no visible change was detected 
in electrophoretic pattern of VRV-PL-V when incubated with 
extracts (data not shown), excludes the proteolytic degradation as a 
potential mechanism [10], and the most likely mechanism for anti-
PLA2 and its associated inflammatory activities by this extract could 
be due to the direct binding of the constituents of the extract with 
svPLA2s active site, as it was observed that their was concernment 
inhibition of enzymatic and edematigenic activity of VRV-PL-V. 
Further, the ethanolic extract of A. paniculata inhibiting both in vitro 
PLA2 enzymatic activity and in vivo edema inducing activity of VRV-
PL-V, suggests a strong correlation between lipolytic activity and 
pro-inflammatory activity inhibition. It can be viewed that A. 
paniculata ethanolic extract can be developed for topical application, 
as effective anti-ophidian formulation, which contains potent anti-
PLA2 molecules. 
CONCLUSION 
The ethanolic extract of A. paniculata effectively inhibited the multi-
toxic PLA2 of Daboii rusellii pulchella i.e., VRV-PL-V and its associated 
inflammatory activities like edema. It was found that there is a 
strong correlation between lipolytic activity and pro-inflammatory 
activity inhibition. Therefore, the study suggests that the extract 
possess potent anti-ophidian agents that could be developed as a 
potential therapeutic agent against snake bite and also against 
inflammatory related diseases. This study also substantiates their 
anti-inflammatory properties by neutralizing the edema inducing 
activities of multi-toxic PLA2 i.e., VRV-PL-V. Further in-depth studies 
on compounds present and the mechanism responsible for the anti-
PLA2 activity viz anti-inflammatory activity will be interesting, to 
development them as a new class of anti-ophidian and anti-
inflammatory agents for therapeutic applications. 
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